Takeda

CUVITRU

Manufacturer:

Takeda

Cuvitru HCPCS:

J1555

HCPCS Code Descriptor:

Injection, immune globulin (cuvitru), 100 mg

Category:

J Code

Cuvitru NDCs:

00944-2850-09, 00944-2850-07, 00944-2850-01, 00944-2850-03, 00944-2850-05

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Cuvitru CPT Codes:

Potential CPT administration codes for Cuvitru can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cuvitru:

CUVITRU is an Immunoglobulin drug manufactured by Takeda and administered via the Subcutaneous route of administration. The J Code: J1555 is aligned to the drug CUVITRU.

ACCESS PRICING AND MORE BY REGISTERING

J1555 Added Date:

January 1, 2018

J1555 Effective Date:

January 1, 2018

J1555 Termination Date:

HCPCS Active

Cuvitru billing and coding information can be found through Takeda at the link below:
Cuvitru patient assistance information can be found through Takeda Patient Support at the URL: https://www.cuvitru.com/patient-support
CUVITRU prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for CUVITRU. Please check back in a few weeks.